Search for: "In Re Bristol Associates, Inc."
Results 21 - 40
of 72
Sorted by Relevance
|
Sort by Date
1 Apr 2010, 3:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: US: District Court S D New York: ‘Isolated DNA’ patents fail to claim patentable subject matter: Association for Molecular Pathology and ACLU v. [read post]
25 Apr 2018, 11:50 am
Interstate Warehousing, Inc., 2017 IL 121281 and State ex rel. [read post]
12 May 2022, 6:45 am
McNeil-PPC, Inc., 786 F. [read post]
5 Jun 2013, 5:29 am
Bristol-Myers Squibb, 97 F. [read post]
27 May 2022, 4:00 am
American Hotel Management Associates, Inc. v. [read post]
18 Mar 2011, 10:04 am
Bristol-Myers Squibb, 97 F. [read post]
9 Nov 2009, 6:01 am
"They're drivers that knowingly speed. [read post]
19 Jul 2022, 2:59 pm
The authors of this guest post are: Doug Greene, BakerHostetler, Leader, Securities and Governance Litigation Team; Genevieve York-Erwin, BakerHostetler, Partner; Mike Tomasulo, Baldwin Risk Partners, Managing Partner, Management Liability National Practice Leader: Emily Baxter, BakerHostetler, Associate; and Alex Karambelas, BakerHostetler, Associate. [read post]
26 Mar 2011, 5:00 pm
Bristol-Myers Squibb Co. v. [read post]
14 Dec 2011, 4:45 am
Pelton & Associates, PLLC. [read post]
28 Nov 2006, 4:11 pm
Elan Pharms., Inc. v. [read post]
15 Apr 2011, 6:02 am
Bristol-Myers Squibb, 1998 WL 812318, at *46 (M.D. [read post]
20 Feb 2011, 9:44 pm
Global Global – General Fail to protect associated IC (no. 5 in our list of IP mistakes) (IP Think Tank) An open approach to IP risks – Onzo approach (IP finance) WTO GI discussions gather speed, parties watchful until negotiations (IP Watch) That IP advice for SMEs: the advisers respond (IPKat) Discovery of Coca-cola’s secret formula? [read post]
2 Nov 2010, 1:40 am
Natural Res. [read post]
25 Apr 2015, 11:03 am
Many modern longitudinal epidemiologic studies and clinical trials use survival analysis and time windows to identify latency or time lagged outcomes in association with identified exposures. [read post]
11 May 2010, 4:53 am
However, it appears generally acknowledged that this trend halted in 2009 with a decision titled In re Bose Corp. [read post]
23 Jul 2012, 7:33 am
In In re Pfizer Inc. [read post]
21 Jun 2010, 9:57 am
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme is upon us. [read post]
26 Feb 2015, 5:00 am
One of our readers sent us that brief (a publicly filed document) and asked us to comment.So we will, but we’re not identifying either the case or the plaintiff’s lawyer – if you’re reading, you know who you are.To us, the plaintiff’s proposition is, in one word, absurd. [read post]
21 Jun 2012, 7:40 am
Bristol-Myers Squibb Co., 2009 WL 5216982, at *5-6 (D.N.J. [read post]
